CrunchBase is hiring! Check out our open positions →
Register | Login or Login

Exit

Acquired byAlexion Pharmaceuticals
Date12/11

General Information

Websiteenobia.com
Twitter@Enobia
CategoryBioTech
Employees
Founded1997
DescriptionGenetic bone disorder treatment

Offices

Quebec, CAN
2901, Rachel Street East, #23
Montreal,
Quebec, H1W 4A4, CAN

People

Chairman of our board of directors
Vice President, Global Metabolic Diseases Franchise.
Board of Directors
Board of Directors
Board of Directors
Board of Directors
Board of Directors
Board of Directors
Show All People

Funding

Tags

Enobia Pharma

Enobia develops therapies to treat serious genetic bone disorders for which there are no approved treatments.

Recent Milestones

Videos

Screenshots

Sources

  1. Alexion Pharmaceuticals to Acquire Enobia Pharma Corp. (finance.yahoo.com) [edit]
  2. researchview (researchviews.com) [edit]
  3. enobia.com [edit]
  4. Enobia Raises US$50M from Current Investors in Series C Financing (enobia.com) [edit]
  5. Enobia Pharma Raises US $40 million (enobia.com) [edit]
Edit This Page
Last Edited 6/18/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy